Absci (NASDAQ:ABSI) used a presentation at the 44th JPMorgan Healthcare Conference to outline recent platform updates and provide a timeline for upcoming clinical data in androgenic alopecia and ...
Illumina launched the Billion Cell Atlas to train AI on one billion single cells. AstraZeneca, Merck and Lilly are founding ...
This is “bigger” than the ChatGPT moment, Lieberman wrote to me. “But Pandora’s Box hasn’t been opened for the rest of the ...
Anthropic’s Cowork brings Claude Code–style AI agents to the desktop, letting Claude access and manage local files and browse ...
Vampirella: Armageddon #7 hits stores Wednesday! Can the rescue party save Vampirella from Hell, or will they need rescuing ...
The HASH vs ICHI lawsuit presents claims for crypto fraud and theft for U.S. courts.According to the lawsuit, highly ...
Leveraging modular gene editors and new regulatory pathways, Aurora will develop and commercialize therapies that can be rapidly tailored to many rare variants -- Founded by CRISPR pioneers Jennifer ...
The site, which will cost about €10.0 billion ($11.7 billion) to complete, will be the third-largest of the company’s Verbund ...
The Admiral Twin Drive-In in Tulsa stands as a magnificent time capsule where cinema magic meets starlit Oklahoma skies, creating an experience that will have you wondering why you waited so long to ...
The Admiral Twin Drive-In in Tulsa stands as a magnificent time capsule where cinema magic meets starlit Oklahoma skies, drawing movie lovers from Broken Arrow to Bartlesville and beyond. Remember ...
Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback